May 16, 2019
Joshua Zeichner, MD, FAAD; and Diamant Thaçi, MD
Diamant Thaçi, MD, Professor and Head, Comprehensive Center for Inflammation Medicine, University of Lubeck, Germany, and host Joshua Zeichner, MD talk about new biologic treatments available and in the pipeline for atopic dermatitis. They share their real-world experiences with safety and efficacy, as well as potential side effects. Dr. Thaçi, who is also chairing the TARGET-DERM study designed to deliver real-world evidence for several immune-mediated inflammatory skin conditions, initially focusing on patients with atopic dermatitis, also discusses our changing understanding of atopic dermatitis.
Joshua Zeichner, MD, FAAD; and Mathew Avram, MD